SCHEMBL5266533

SCHEMBL5266533

COC(=O)c1cc(-c2cnn(C)c2)n(-c2ccc(Cl)nn2)n1

nearest known ligand 0.41

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
SMN1; SMN2 Q16637 2/20 0.41
MEN1 O00255 1/20 0.38
KMT2A Q03164 1/20 0.38
ALOX5 P09917 2/20 0.38
PTGS2 P35354 1/20 0.37
FAAH O00519 1/20 0.36
MGLL Q99685 1/20 0.36
LRRK2 Q5S007 2/20 0.36
FYN P06241 1/20 0.36
SLC16A3 O15427 1/20 0.35
SLC16A1 P53985 1/20 0.35
NTRK1 P04629 1/20 0.35
PDGFRB P09619 1/20 0.35
KIT P10721 1/20 0.35
FGFR1 P11362 1/20 0.35
FGFR3 P22607 1/20 0.35
FLT3 P36888 1/20 0.35
MALT1 Q9UDY8 1/20 0.34
IRAK4 Q9NWZ3 1/20 0.34
ABL1 P00519 1/20 0.34

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL5272583 0.84 SMN1; SMN2 (0.42) SMN1; SMN2MEN1KMT2AALOX5PTGS2
SCHEMBL5269328 0.83 SMN1; SMN2 (0.43) SMN1; SMN2MEN1KMT2AALOX5PTGS2
SCHEMBL5269292 0.81 SMN1; SMN2 (0.44) SMN1; SMN2MEN1KMT2AALOX5PTGS2
SCHEMBL2910701 0.80 SMN1; SMN2 (0.47) SMN1; SMN2MEN1KMT2AALOX5PTGS2
SCHEMBL5269426 0.79 SMN1; SMN2 (0.38) SMN1; SMN2MEN1KMT2AALOX5PTGS2
SCHEMBL5266025 0.78 RPA1 (0.44) SMN1; SMN2LRRK2
SCHEMBL5522528 0.77 ALOX5 (0.40) SMN1; SMN2MEN1KMT2AALOX5PTGS2
SCHEMBL5266028 0.77 RAB9A (0.39) SMN1; SMN2MEN1KMT2AALOX5PTGS2
SCHEMBL5268843 0.75 SMN1; SMN2 (0.38) SMN1; SMN2MEN1KMT2AALOX5PTGS2
SCHEMBL2917351 0.75 SLC16A3 (0.40) SMN1; SMN2MEN1KMT2AFAAHMGLL

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20070254881-A1 Pyrazole Derivative DAIICHI PHARMACEUTICAL CO., LTD. (JP) 2007-11-01 US disclosed
EP-1785418-A1 PYRAZOLE DERIVATIVE DAIICHI PHARMACEUTICAL CO., LTD. (JP) 2007-05-16 EP disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20070254881-A1 Pyrazole Derivative PTGER1, PTGS1, PTGER2 SMN1; SMN2 3490/4885MEN1 3587/4885KMT2A 3446/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.